• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

depression

  1. ADA accommodations experiences

    Does anyone have experience with ADA accommodations either for yourself or someone you know well that you could share. Field pharma reps with any sort of mental impairment (cognitive fx, Anxiety, MDD, ADD, Panic or anything similar)? If so what types of accommodations were made and was the rep...
  2. Myrbetriq Sales

    Been out a while. Has Myrbetriq hit the number #1 prescribed OAB agent? Or Has the fact Vesicare is going generic stopped that? What about the fact a combo drug with those two will have crap coverage? How are the feeling of the sales force?